Match Document Document Title
DE102010034968B4 Polymerizable compounds and liquid-crystal media  
Liquid-crystalline medium which comprises one or more compounds selected from the compounds of the formulas IA-1 to IA-10contains wherein R1' to R5' each independently of one another hydrogen,...
DE102017003004A1 Cationic polymers with D-fructose substituents  
The invention relates to novel cationic polymers which are D-fructose conjugated, whereby they are able to interact selectively with specific structural elements on cell surfaces. The task was to...
DE102014210662A1 Device and method for obtaining glycoglycerolipids and glycosphingolipids from lipoid phases  
The present invention relates to a device and method for the gentle and hydrolysis-free separation of glycoglycerolipids as well as glycoglycerolipids and glycosphingolipids from a lipoid phase...
DE102012221519A1 Process for the isolation of rhamnolipids  
The invention relates to a method for isolating rhamnolipids
DE102006053385B4 Enterococcus faecalis antigen  
Enterococcus faecalis strain type 5 antigen, which comprises at least one disaccharide unit, which has the following formula: where R1 OH is X = O, Y = O and CA Lactyl is.
DE102010034968A1 Polymerizable compounds and liquid crystal media  
The invention relates to polymerizable compounds of the formula I, where P, Sp, R1, R2, A1, A2, A3, Z1, Z3, V, m, n, o, x and y have the meanings given in claim 1, and liquid-crystalline media...
DE19823062B4 A process for the production of an alkyl glycoside  
A process for producing an alkyl glycoside, comprising the steps of: a) mixing a hydrated, solid sugar with a straight-chain or branched, saturated or unsaturated alcohol having 8 to 22 carbon...
DE102008053549A1 Glucosylglycerol containing composition  
The invention relates to a composition comprising 20-80 wt .-% wt .-% glucosylglycerol and 0.5-20 one or more mono- and / or disaccharides. Surprisingly, it has been found that a particular...
DE19943491B4 Improved compressed  
A process for producing a compressed product of isomaltulose, isomalt, or isomalt variants, wherein the isomalt variants 1,6-GPS and 1,1-GPM-containing mixtures are that through to deviate from...
DE19937019B4 A method for producing 4-aryl-2-butanols from Taxus wallichiana  
The present invention provides a process for the production of two molecules of 4-aryl-2 butanols having the general formula 1 given below:Wherein R=H or glucose from the leaves of Taxus...
DE102008012295A1 Mixture for the production of rapidly disintegrating tablets  
Isomalt-containing mixture, comprising a) 60-97 wt .-% agglomerated isomalt, b) 1-25 wt .-% cross-linked polyvinylpyrrolidone, c) 0.1-15 wt .-% lubricant, d) 1-15 wt. -% water-insoluble,...
DE102008012015A1 Improved isomalt-containing compressed formulations and methods for their preparation  
The present invention relates to improved isomalt-containing compacts and methods for their preparation.
DE10128250B4 Glykolipidderivate new, processes for their preparation and compositions comprising them  
The present invention is a compound of general formula (I) or a pharmaceutically acceptable salt of,wherein W represents carbon chain from 9 to 17 which containing double bond or hydroxy group...
DE69809362T3 Specially shaped maltitol, containing these crystalline compositions and methods for their preparation  
New crystalline maltitol forms containing: (a) bipyramidal; (b )prismatic; or (c) a mixture of bipyramidal and prismatic crystals. The bipyramidal-form crystals comprise regular octahedra of...
DE10319917B4 Process for the selective carbohydrate oxidation using a supported gold catalysts  
Selective oxidation of a carbohydrate (mixture) or composition containing a carbohydrates comprises reacting an aqueous solution of the carbohydrate or composition in presence of oxygen and a gold...
DE69838903T2 Sulfonamide derivatives as prodrugs of inhibitors of aspartyl protease  
The present invention relates to prodrugs of a class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of prodrugs of HIV aspartyl...
DE60130669T2 POLYSACCHARIDES having an antithrombotic action, WITH BIOTIN OR A BIOTIN DERIVATIVE COVALENTLY BOUND  
The present invention relates to novel synthetic polysaccharides with antithrombotic activity exhibiting at least one covalent bond with biotin or a biotin derivative and to a process employing...
DE69334174T2 Preparation of carboxylic acid-sugar  
A process for producing a saccharide carboxylic acid or a salt thereof is characterised in that a microorganism belonging to the genus Pseudogluconobacter and capable of oxidizing a hydroxymethyl...
DE60315723T2 Production of polyketides and other natural products  
The present invention relates to production of polyketides and other natural products and to libraries of compounds and individual novel compounds. One important area is the isolation and...
DE102006054213A1 Homogeneous phase acetalation of oligo- or polysaccharide, e.g. for production of acid-crosslinkable cellulose acetals, by reaction with vinyl ether in solution in ionic liquid  
Acetalation of di-, oligo- or polysaccharides (or their derivatives) (I) is carried out by dissolving (I) in at least one ionic liquid (II) and reacting with a vinyl ether (III). Independent...
DE102006053690A1 New anionic cyclopentadienyl-carbohydrate compounds useful in the preparation of metallocene-carbohydrate compound, which is useful to treat cancer  
Anionic cyclopentadienyl-carbohydrate compounds (I), are new. Anionic cyclopentadienyl-carbohydrate compounds of formula (I), are new. m : 0-10 (preferably 1); ER1 : OH, alkoxy, nucleo-base or...
DE102006053385A1 Enterococcus faecalis and / or Enterococcus faecium antigen  
The This invention relates generally to the field of detection and prevention of infectious diseases caused by Enterococcus faecalis and / or Enterococcus faecium caused. In particular relates to...
DE60129929T2 METHOD FOR PRODUCING FUNCTIONALIZED BETA- (1.3) -GLUCANDERIVATEN  
The present invention relates to a novel method of chemically preparing functionalized derivatives of beta-(1,3)-glucans, enabling obtaining oligosaccharides which are free or which comprise...
DE19758788B4 Stereo-selective hydrogenation of sugars to sugar alcohols with good purity - in aqueous solution, at high temperature and pressure, uses catalyst mixture of Raney metal and its alloy with inert core and active shell  
Hydrogenation of 1 or more sugars to sugar alcohols in aqueous solution comprises using hydrogen (H2) at elevated temperature and pressure and a catalyst with an inert core and catalytically...
DE602004007662T2 RAPAMYCIN-carbohydrate DERIVATIVES  
This invention provides modified rapamycins that have specific monosaccharide(s), oligosaccharide(s), pseudosugar(s) or derivatives thereof attached through a linker to create rapamycin...
DE69935250T2 OLEANDOMYCIN DERIVATIVES  
The invention relates to novel compounds from the class of the macrolide antibiotic oleandomycin of the general formula (I)whereinR1 has the individual meaning of -CH2CH3 group, of a fragment of...
DE102007018551A1 Preparing gemcitabine comprises reducing a dihydro-furan-2-one compound to give a furan compound, activating the hydroxyl group and reacting with a protected cytosine to give a protected nucleoside and terminal protection of the nucleoside  
Preparation of gemcitabine comprises reducing a dihydro-furan-2-one compound (16A) to give a furan compound (19), activating the hydroxyl group by converting into a sulfonate (mesylate), reacting...
DE102005033903B4 Perfluoroalkyl-containing complexes, processes for their preparation, and their use and pharmaceutical compositions containing them  
Perfluoroalkyl-containing metal complexes (I) are new. Perfluoroalkyl-containing metal complexes of formula K1>-L(Q-R)-N(A)-X-Rf (I), are new. R : mono- or oligosaccharide bound with one hydroxy...
DE69835201T2 neoglycoproteins  
Polyamide conjugates comprising either (a) a xenoantigenic group; or (b) a biologically active group and a macromolecular, macro- or microscopic entity; bound to a polyamide backbone, processes...
DE60309345T2 INOSITOLDERIVATISIERTE PHOSPHOLIPIDS  
The present invention relates to a phospholipid derivative having a substituted or unsubstituted polyhydroxylated aliphatic carbocycle attached to the sn-1 or sn-2 position of the glycerol...
DE60215530T2 NEW glycolipid, AND REMEDIES FOR AUTOIMMUNE THIS IS AS ACTIVE INGREDIENT  
Glycolipid compounds (I) are new. Glycolipid compounds of formula (I) are new. [Image] R 1aldopyranose residue; R 2H or OH; R 3CH 2, CH(OH)CH 2 or CH=CH; R 4H or CH 3; x : 0-35; y+z : 0-3....
DE60027905T2 Glycoconjugates, glycoamino acid, THEIR INTERMEDIATES, AND THEIR USE  
The present invention provides novel n-alkenyl glycosides and glycoconjugates, n-alkyl glycoamino acids, and methods for the synthesis thereof. In another aspect, the present invention provides...
DE69636310T2 A process for producing a Raney catalyst  
To obtain a Raney catalyst for fixed bed permitting a continuous use with a high initial activity and to produce a high purity sugar-alcohol at a low cost using the same. For this object,...
DE10242062B4 Hydrogenated condensed palatinose, processes for their preparation and their use  
Foodstuffs, sweeteners or pharmaceutical compositions containing hydrogenated condensed palatinose (I) are new. Foodstuffs, sweeteners or pharmaceutical compositions containing hydrogenated...
DE19930177B4 Intermolecularly associating compounds and their use  
connection of the general formula (I) X (B)m (I)in which X an m-valent moiety and for CH4-m; NH3-m; N+H4-m; > P- (when m = 3); > P+<(When m = 4); > B- (when m = 3); a linear atomic group C2H6-m; >...
DE102005033903A1 New perfluoroalkyl-containing metal complexes, useful for production of contrast agents for use in e.g. NMR and X-ray diagnostics, necrosis imaging and in radiodiagnostics and radiotherapy  
Perfluoroalkyl-containing metal complexes (I) are new. Perfluoroalkyl-containing metal complexes of formula K1>-L(Q-R)-N(A)-X-Rf (I), are new. R : mono- or oligosaccharide bound with one hydroxy...
DE69735851T2 METHOD FOR ACTIVATION OF HUMAN, ANTIGEN activating CELLS ACTIVATED HUMAN, ANTIGEN ACTIVATING CELLS AND USES THEREOF  
A method for activating human antigen presenting cells characterized by culturing in vitro antigen presenting cells with a human origin together with at least one of glycoside compounds...
DE60119492T2 purine derivatives  
The present invention relates to compounds of the class of purin-2-ylcarboxamides, useful as anti-inflammatory agents, having the formula:and pharmaceutically acceptable salts and solvates...
DE60118207T2 NEW IMMUNOEFFECTORVERBINDUNGEN  
This invention provides compounds containing a 2-deoxy-2-amino-beta-D-glucopyranose (glucosamine) glycosidically linked to a cyclic aminoalkyl (aglycon) group. The invention further provides...
DE69833260T2 COMPOSITION WITH ALPHA-glycosyl STRENGTHENING CELLULAR IMMUNOGENICITY  
A composition for potentiating the immunogenicity of tumor cells or pathogen-infected cells, which contains a compound having the alpha -glycosylceramide structure, salts thereof or solvates of...
DE69930412T2 ANTI- (RETRO) VIRAL CONJUGATES OF SACCHARIDES AND ACETAMIDINO- OR guanidino  
Conjugates of a saccharide and an acetamidino- or guanidino-compound, of the formula:wherein A is CH3 or NH2; X is a linear or branched C1-C8 alkyl chain optionally containing hydroxy, amino...
DE60024580T2 Derivatized REDUCED maltooligosaccharides  
Disclosed are derivatized malto-oligosaccharides and methods for the preparation thereof. In accordance with the disclosed invention, a malto-oligosaccharide is hydrogenated to thereby obtain a...
DE102005005199A1 Use of alkyl glucoside for obtaining or improving the microbiological stability of cosmetic or dermatological preparations, which contain preservatives and for protecting organic products from the attack of the mycobiont  
Use of alkyl glucoside (I) for obtaining or improving the microbiological stability of cosmetic or dermatological preparation, which contains preservatives. Use of alkyl glucoside of formula (I)...
DE69434571T2 Propane-1,3-disulphonsäure and their pharmaceutically acceptable salts for the treatment of amyloidosis  
Therapeutic compounds and methods for inhibiting amyloid deposition in a subject, whatever its clinical setting, are described. Amyloid deposition is inhibited by the administration to a subject...
DE69635271T2 PROCESS FOR TREATING Amyloidosis  
Therapeutic compounds and methods for inhibiting amyloid deposition in a subject, whatever its clinical setting, are described. Amyloid deposition is inhibited by the administration to a subject...
DE60023722T2 Oligosaccharides which are derived from ribose-phosphate Ribtol and vaccines containing these oligosaccharides  
The present invention relates to the field of the Medicine, in particular with the chemical synthesis of oligosaccharide mixtures derived of ribose-ribitol-phosphate, which are used as active...
DE60015540T2 Bleach BASED INULIN  
The invention relates to the use of a partially acylated fructan, in particular a partially acylated inulin, having a degree of substitution with acyl groups of 0.4-2.5 and a degree of...
DE19603629B4 A process for preparing alkyl glycoside  
process for the production of an alkyl glycoside by reaction of a saccharide and a monohydric alcohol or phenol, which process comprises comprising steps of: implementation of Reaction of the...
DE60111467T2 A hollow fibrous organic nanotube and process for its preparation  
A novel hollow fibrous organic nanbtube can be produced by a simple procedure from a readily available and inexpensive natural material, which is regenerable and has a wide range of application....
DE60204859T2 furanosylnucleosiden 2'-halo-beta-L-arabino-process for the preparation of  
The present invention is directed to the process for the preparation of 2'-deoxy-2'-halo-beta-L-arabinofuranosyl nucleosides, and in particular, 2'-deoxy-2'-fluoro-beta-L-arabinofuranosyl thymine...